On the heels of the Point of Care Marketing Association’s 2022 Industry Summit and in partnership with leading medical market research company MedSurvey, Havas Media Group (HMG) revealed findings from a new research study examining the matrix of influence surrounding prescribing drugs for patients. The findings identify who beyond MDs exerts influence over prescribing decisions, as well as the concerns, behaviors, trigger moments, and media habits of these influencers.
epocrates, an athenahealth Inc. company that delivers digital clinical decision support to prescribers, shared its commitment to accelerate the company’s fast-growing commercial business and further invest in and innovate its commercial product offerings, following a period of tremendous change in the pharmaceutical industry. To help enhance and broaden epocrates’ services, the company recently brought on Matt Titus – an industry veteran of 13 years – to serve as the organization’s vice president, chief commercial officer.
The U.S. Department of Homeland Security (DHS) announced it is requiring that non-U.S. essential workers such as truck drivers and nurses who are crossing land borders be fully vaccinated against COVID-19, effective January 22.
The numbers of nurses around the world are falling further just as the Omicron coronavirus spreads, and there is a also an imbalance as Western countries step up recruitment of healthcare workers from African and other poorer countries, the International Council of Nurses said on December 10.
POCN, the largest Nurse Practitioner (NP) and Physician Associate (PA) network in the United States, and HealthSTAR Communications, an integrated omni-channel agency network uniquely positioned to deliver cutting-edge proprietary technology and capabilities to healthcare professionals and patients, partnered to bring POCN’s best-in-class Live Local peer-to-peer educational series focused on NPs and PAs.
India postponed exams for trainee doctors and nurses on May 3, freeing them up to fight the world’s biggest surge in coronavirus infections, as the health system crumbles under the weight of new cases and hospitals run out of beds and oxygen.
Mobile Research Nursing Helps Mitigate Challenges of Large Vaccine Trials
Case Studies, Clinical Trials, Clinics, Contract Research Organization (CRO), Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Data, Mobile Research Nursing, Nurses, Patient Enrollment, Public Health Emergencies, R&DLarge vaccine trials that are extensive both in size and scope tax the resources of sponsors and contract research organizations (CROs), particularly when the trials seek to compress a process that ordinarily takes years. Rapid but safe implementation of these vaccine studies’ new protocols is pushing trial design to the limit.
The microscopic organisms living in our intestines may influence the severity of Covid-19 and the body’s immune response to it, and could account for lingering symptoms, researchers reported.
‘Race against time’: First Americans vaccinated as U.S. death toll passes 300,000
"Operation Warp Speed" Initiative, Andrew Cuomo (NY), BioNTech, BNT162b2 (Pfizer and BioNTech), Clinical Trials, Coronavirus immunizations, Covid-19 Epicenter, COVID-19 Vaccines, Death Tolls, Governors, New York, Nurses, Pfizer, R&D, Rollouts, Walter Reed National Military Medical CenterAn intensive care unit nurse became the first person in New York state to receive the Pfizer/BioNTech Covid-19 vaccine on Dec. 14, marking a pivotal turn in the U.S. effort to control the deadly virus.
Covid-19 shots could reach first Americans by mid-December, top health official says
'Herd Immunity', BioNTech, Coronavirus Disease (COVID-19) Pandemic, COVID-19 cases, COVID-19 inoculations, Doctors, Emergency Use Authorization, Immunizations, Joe Biden, Nurses, Pfizer, U.S. Centers for Disease Control and Prevention, U.S. governmentU.S. healthcare workers and others recommended for the nation’s first Covid-19 inoculations could start getting shots within a day or two of regulatory consent in December, a top official of the government’s vaccine development effort said.